在国家“重大创新药创制”专项支持下，以自主创新药物尽快进入国际主流市场为宗旨，我机构项目《建立符合国际新药研究规范的临床前安全评价技术平台》课题获得政府立项资助。

With the support of national specialized projects for “significant new drugs creation” ，taking independent innovation drugs entering the international mainstream markets earily as the aim，our subject “Establishing technology platform for preclinical evaluation on new drugs in accordance with international standards” gained govermental financial assistance.